XTL BIOPHARMACEUTICALS LTD (XTLB)

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Address

XTL BIOPHARMACEUTICALS LTD
NEW YORK, NY 10016

Founded

1993

Number of Employees

8

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)